Haleon (HLN) Stock Price, News & Analysis

Company Overview

Haleon plc (NYSE: HLN) is a global consumer healthcare company that develops, manufactures and markets products for everyday health and wellness needs. Its portfolio spans oral health, pain relief, respiratory health, vitamins and supplements, digestive health, and therapeutic skin care.

Haleon’s well-known brands include Sensodyne, Polident, parodontax, Voltaren, Panadol, Advil, Centrum, Emergen-C, Theraflu, Otrivin, Calpol, ChapStick and Excedrin. The company sells its products through pharmacies, supermarkets, mass retailers, e-commerce platforms and other healthcare channels.

Haleon was formed through the demerger of GSK’s consumer healthcare business and became an independent company in 2022. Headquartered in Weybridge, England, it serves consumers in markets around the world, with operations and products tailored to various regional healthcare needs.

Key Stats

• Today's Range: $9.20 to $9.31
• 50-Day Range: $9.19 to $10.27
• 52-Week Range: $8.65 to $11.28
• Volume: 25.25 million shs
• Average Volume: 9.51 million shs
• Market Capitalization: $40.75 billion
• P/E Ratio: 23.76
• Dividend Yield: 1.30%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Haleon Stock Analysis - MarketRank™

Haleon scored higher than 59% of companies evaluated by MarketBeat, and ranked 88th out of 171 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Haleon has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 2 strong buy ratings, 2 buy ratings, 4 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Haleon has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 7.02%

Earnings Growth

Earnings for Haleon are expected to grow by 7.02% in the coming year, from $0.57 to $0.61 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Haleon is 23.71, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.92.

Price to Earnings Ratio vs. Sector

The P/E ratio of Haleon is 23.71, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 14.18.

Price to Earnings Growth Ratio

Haleon has a PEG Ratio of 2.05. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Haleon has a P/B Ratio of 1.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.35% of the float of Haleon has been sold short.

Short Interest Ratio / Days to Cover

Haleon has a short interest ratio ("days to cover") of 1.83, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Haleon has recently increased by 15.53%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Haleon pays a meaningful dividend of 1.31%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Haleon does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Haleon is 30.77%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Haleon will have a dividend payout ratio of 19.67% next year. This indicates that Haleon will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.99

News Sentiment

Haleon has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Haleon this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for HLN on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Haleon insiders have not sold or bought any company stock.

Percentage Held by Institutions

6.67% of the stock of Haleon is held by institutions.

Company Calendar

• Last Earnings: 2/27/2025
• Record date for 9/17 Dividend: 8/14/2026
• Ex-Dividend for 9/17 Dividend: 8/14/2026
• Dividend Payable: 9/17/2026
• Today: 9/18/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NYSE:HLN
• CIK: 1900304
• Web: www.haleon.com
• Phone: 44-19-3282-2000
• Fax: N/A
• Employees: 24,535
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 23.71
• Forward P/E Ratio: 16.20
• P/E Growth: 2.05
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.38
• Current Ratio: 0.69
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: $11.15 billion
• Price / Sales: 3.64
• Cash Flow: $0.61 per share
• Price / Cash Flow: 15.14
• Book Value: $4.88 per share
• Price / Book: 1.89

Miscellaneous

• Outstanding Shares: 4,398,274,000
• Free Float: N/A
• Market Cap: $40.62 billion
• Optionable: Not Optionable
• Beta: 0.12